Turnstone Biologics Corp. Financing Cash Flow
Turnstone Biologics Corp. reported Financing Cash Flow of $11.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-08-08
- Turnstone Biologics Corp. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $0.00.
- Turnstone Biologics Corp. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $59.00K, a 99.92% decline year-over-year.
- Turnstone Biologics Corp. net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was -$169.00K, a 3480.00% decline year-over-year.
- Turnstone Biologics Corp. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was $78.30M.
- Turnstone Biologics Corp. net cash provided by (used in) financing activities for fiscal 2024 was $11.00K, a 99.99% decline from fiscal 2023.
- Turnstone Biologics Corp. net cash provided by (used in) financing activities for fiscal 2023 was $77.05M.
- Turnstone Biologics Corp. net cash provided by (used in) financing activities for fiscal 2022 was -$2.66M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $59.00K derived: sum of 2 quarters · filed 2025-03-31 | $11.00K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $11.00K 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | -$48.00K 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | -$169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $78.13M derived: sum of 2 quarters · filed 2025-03-31 | $77.86M derived: sum of 3 quarters · filed 2025-03-31 | $77.05M 10-K · filed 2025-03-31 |
| 2023-09-30 | $78.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $78.03M derived: sum of 2 quarters · filed 2024-11-12 | $77.22M 10-Q · filed 2024-11-12 | $77.22M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$1.08M 10-Q · filed 2024-08-14 | -$1.08M derived: sum of 3 quarters · filed 2024-08-14 | -$3.89M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$815.00K 10-Q · filed 2024-05-13 | -$810.00K derived: sum of 2 quarters · filed 2024-05-13 | -$3.62M derived: sum of 3 quarters · filed 2024-05-13 | |
| 2022-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$2.81M derived: sum of 2 quarters · filed 2024-03-22 | -$2.66M 10-K · filed 2024-03-22 | |
| 2022-09-30 | -$2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$2.66M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $150.00K 10-Q · filed 2023-09-01 |